Home / Health / Weight Loss Jabs: Wealth Divide Fuels Inequality
Weight Loss Jabs: Wealth Divide Fuels Inequality
18 Feb
Summary
- Women comprise nearly 80% of private weight loss jab prescriptions.
- Those in poorer areas are less likely to receive jabs despite higher obesity.
- NHS rollout of Mounjaro is a 12-year phased plan, prioritizing need.
Research indicates a significant disparity in access to weight loss medications, with women and the middle classes dominating private prescriptions. Almost 80% of these private prescriptions are for female patients, and the 30 to 49 age group shows the highest uptake across both genders. The findings highlight an inequality, as individuals in more deprived areas are about a third less likely to receive these jabs compared to those in less deprived areas. This is particularly concerning given that people in poorer areas often start treatment at a heavier weight.
